Will Cell and Gene Therapies Reach a Tipping Point? – Genetic Engineering & Biotechnology News (press release)
Genetic Engineering & Biotechnology News (press release) |
Will Cell and Gene Therapies Reach a Tipping Point?
Genetic Engineering & Biotechnology News (press release) “With over 750 regenerative medicine firms world-wide, 271 cell and gene therapies in Phase I/II, 66 products in Phase 3, and promising CAR-T cell therapy results and marketed therapies, there's a lot more optimism now about this sector,” states Kurt … |
